MedTrace Logo

Diet and Depression

NCT06252701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-11-21

No results posted yet for this study

Summary

This study is a pilot open label crossover trial to assess the feasibility and acceptability of reducing ultra- processed foods (UPF) in a personalized manner from the diets of patients with major depressive disorder who eat a large percentage of UPF.

Conditions

Interventions

BEHAVIORAL

Reduction of Ultra-processed foods

Reduction of Ultra-processed foods for four weeks.

Sponsors & Collaborators

Principal Investigators

  • D. Nyasha Chagwedera, MD, PhD · University of California, San Francisco

  • Andrew Krystal, MD, MS · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2025-06-18
Completion
2025-06-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06252701 on ClinicalTrials.gov